Literature DB >> 12487634

How can coronary flow reserve be altered by severe aortic stenosis?

Attila Nemes1, Tamás Forster, Albert Varga, Andrea Vass, Angela Borthaiser, Attila Pálinkás, Miklós Csanády.   

Abstract

UNLABELLED: The coronary flow reserve, a well-known characteristic of the distensibility of the coronary arteries, can be measured by means of dipyridamole stress transesophageal echocardiography. This study compared the coronary flow reserve in patients with normal coronary arteries with aortic stenosis (Group 1), in patients with normal coronary arteries without aortic stenosis (Group 2), and in patients with significant left anterior descending coronary artery disease (Group 3). PATIENTS AND METHODS: Groups 1 and 2 were comprised of 21 patients each, while Group 3 was comprised of 37 patients. Transesophageal stress echocardiography was carried out according to a standard protocol, with a vasodilator stimulus of dipyridamole in a dose of 0.56 mg/kg over 4 minutes. The coronary flow reserve was calculated as the ratio of posthyperemic to basal peak (CFR) and mean (mean CFR) diastolic flow velocities.
RESULTS: The left ventricular mass and left ventricular mass index were significantly higher in Group 1 than in Groups 2 and 3. The coronary flow reserve and the posthyperemic mean diastolic flow velocities were significantly lower, while the resting mean diastolic flow velocities were significantly higher in Groups 1 and 3 than in Group 2.
CONCLUSIONS: In patients with aortic stenosis and a normal coronary angiogram, the coronary flow reserve is significantly lower, similarly as in the case of significant left anterior descending coronary artery disease. In severe aortic stenosis with left ventricular hypertrophy, stress transesophageal echocardiography is unable to distinguish between the drop in coronary flow reserve caused by a vascular or a myocardial component, and therefore, not suitable for the selection of patients with significant coronary artery disease, even in cases of left anterior descending coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12487634     DOI: 10.1046/j.1540-8175.2002.00655.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  6 in total

1.  Understanding coronary artery bypass transit time flow curves: role of bypass graft compliance.

Authors:  Matija Jelenc; Blaž Jelenc; Tomislav Klokočovnik; Nikola Lakič; Borut Geršak; Ivan Kneževic
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-10-30

2.  Is the coronary flow velocity reserve improvement after aortic valve replacement for aortic stenosis transient? Results of a 3-year follow-up.

Authors:  Attila Nemes; Tamás Forster; Zsolt Kovács; Miklós Csanády
Journal:  Heart Vessels       Date:  2006-05       Impact factor: 2.037

3.  The comparative value of the aortic atherosclerosis and the coronary flow velocity reserve evaluated by stress transesophageal echocardiography in the prediction of patients with aortic stenosis with coronary artery disease.

Authors:  Attila Nemes; Tamás Forster; Attila Thury; Zsolt Kovács; Krisztina Boda; Miklós Csanády
Journal:  Int J Cardiovasc Imaging       Date:  2003-10       Impact factor: 2.357

4.  Coronary microvascular dysfunction, left ventricular remodeling, and clinical outcomes in aortic stenosis.

Authors:  Wunan Zhou; Navkranbir Bajaj; Ankur Gupta; Yee-Ping Sun; Sanjay Divakaran; Courtney Bibbo; Jon Hainer; Viviany Taqueti; Sharmila Dorbala; Ron Blankstein; Pinak Shah; Tsuyoshi Kaneko; Dale Adler; Patrick O'Gara; Marcelo Di Carli
Journal:  J Nucl Cardiol       Date:  2019-05-01       Impact factor: 5.952

5.  Therapeutic vascular compliance change may cause significant variation in coronary perfusion: a numerical study.

Authors:  S Nobari; R Mongrain; E Gaillard; R Leask; R Cartier
Journal:  Comput Math Methods Med       Date:  2012-03-05       Impact factor: 2.238

Review 6.  The Role of Stress Echocardiography in Valvular Heart Disease.

Authors:  Rodolfo Citro; Francesca Bursi; Michele Bellino; Eugenio Picano
Journal:  Curr Cardiol Rep       Date:  2022-08-30       Impact factor: 3.955

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.